N2

Rate-controlled AF — rate/rhythm

Skilled cardiovascular assessment completed. Apical pulse auscultated for one full minute: rate 76, rhythm irregularly irregular at the patient's known baseline for chronic atrial fibrillation; no apical–radial deficit appreciated. BP 126/78 within ordered range; no jugular venous distension; pulses palpable and symmetric; no edema. Patient denies palpitations, lightheadedness, syncope, chest pain, or dyspnea, and reports activity tolerance at baseline. Findings stable from baseline. RN-level assessment was required to confirm adequate rate control and to detect any change in rhythm, rate, or hemodynamic tolerance that would warrant provider notification. Symptoms requiring prompt reporting and the rate-control monitoring plan reinforced; continued skilled monitoring indicated. (Anticoagulation safety and INR monitoring are documented per the Anticoagulation Therapy overlay.)

N3

Stable chronic edema, compression in use

Skilled cardiovascular and peripheral assessment completed. Heart rate 70 and regular; BP 128/76 within ordered range; S1/S2 normal, no S3/S4; no JVD. Bilateral 2+ lower-extremity edema, symmetric and unchanged from the patient's chronic baseline; skin intact, no increased warmth or new tenderness; pulses 2+ and symmetric; capillary refill under 3 seconds. Compression garments donned correctly and tolerated. Patient denies new dyspnea, sudden weight gain, or change in activity. Daily weight stable. RN-level assessment was required to distinguish stable chronic edema from early decompensation and to evaluate compression effectiveness and skin integrity. Elevation, daily-weight thresholds, and skin-monitoring reinforced; continued skilled monitoring indicated.

N4

Post-MI recovery, activity progressing

Skilled cardiovascular assessment completed. Heart rate 66 and regular; BP 118/72 within ordered range; S1/S2 normal, no S3/S4, murmur, or rub; no JVD; pulses 2+ symmetric; no edema. Patient denies chest pain, dyspnea, or palpitations and reports tolerating a graded increase in activity without symptoms. Findings consistent with uncomplicated recovery from recent myocardial infarction. RN-level assessment was required to monitor for post-infarction complications and to evaluate tolerance of the beta-blocker, statin, and antiplatelet regimen, including screening for bradycardia and hypotension. Activity pacing, medication adherence (no abrupt beta-blocker discontinuation), and symptom-recognition criteria reinforced; teach-back accurate. Continued skilled monitoring indicated.

N5

Stable valvular disease, asymptomatic

Skilled cardiovascular assessment completed. Heart rate 74 and regular; BP 126/74 within ordered range; chronic II/VI systolic murmur at the right upper sternal border, unchanged in quality and intensity from baseline; S1/S2 otherwise normal, no S3/S4 or rub; no JVD; pulses 2+ symmetric; no edema. Patient denies syncope, exertional dyspnea, chest pain, or palpitations. Findings stable from prior visits. RN-level assessment was required to detect any change in the known murmur or new symptoms suggesting valvular progression or heart failure. Symptoms warranting prompt reporting reviewed; continued skilled monitoring indicated.

N6

Diuretic monitoring — volume/electrolytes

Skilled cardiovascular assessment completed. Heart rate 70 and regular; BP 120/72 within ordered range; S1/S2 normal, no S3/S4; no JVD; pulses 2+ symmetric; no edema; mucous membranes moist, no signs of volume depletion. Daily weight 158 lb at target, stable over the week with no abrupt loss or gain. Patient denies dizziness, cramping, palpitations, or increased dyspnea. Most recent basic metabolic panel reviewed and within parameters per order. Findings stable. RN-level assessment was required to evaluate diuretic efficacy and to monitor for electrolyte imbalance and volume depletion. Daily-weight thresholds, hydration parameters, and symptoms of imbalance reinforced; continued skilled monitoring indicated.

N7

Interval monitoring — stable, asymptomatic

Skilled cardiovascular assessment completed at the scheduled interval visit. Heart rate 70 and regular; blood pressure 122/74 within the ordered range; S1 and S2 present and normal, no S3, S4, murmur, or rub; no jugular venous distension at 30–45°; peripheral pulses 2+ and symmetric; capillary refill under 3 seconds; no edema. Patient denies chest pain, palpitations, dyspnea, dizziness, or change in activity tolerance, and reports tolerating the cardioactive regimen without adverse effects. Findings are stable and consistent with the established baseline. RN-level assessment was required to detect any interval change in cardiac status and to evaluate the tolerance and effect of the prescribed regimen given the cardiac diagnosis. Symptoms warranting prompt reporting reviewed; continued skilled monitoring indicated.